Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, T-Cell 1Leukemia, B-Cell 1Leukemia 1

Interventions

pegaspargase 2Vincristine 2Methotrexate 2Cytarabine 2ruxolitinib 1palbociclib 1nelarabine 1Prednisone 1Prednisolone 1Panobinostat 1Mitoxantrone 1Mercaptopurine 1Hydrocortisone 1Etoposide 1Doxorubicin 1Dexamethasone 1Daclizumab 1Cyclophosphamide 1Clofarabine 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, T-Cell × nelarabine × Clear all
NCT02518750 2019-04-03

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma

St. Jude Children's Research Hospital

Phase 2 Terminated
3 enrolled 6 charts
LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡